Novo Nordisk and Eli Lilly at odds over consolidation of product liability cases in US court
Eli Lilly is opposed to consolidating the cases, as most of the lawsuits are against Novo Nordisk’s drug, Ozempic, while very few are against Eli Lilly’s similar drug, Mounjaro..
by marketwire
A plaintiff’s request to consolidate a number of US product liability lawsuits against Novo Nordisk and Eli Lilly is causing disagreement between the two pharmaceutical companies, Bloomberg Law reports.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
